![Walter Piskorski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Walter Piskorski
Nessuna posizione attualmente
Storia della carriera di Walter Piskorski
Precedenti posizioni note di Walter Piskorski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/02/1997 | 01/06/2007 |
Armstrong Pharmaceuticals, Inc.
![]() Armstrong Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Amphastar Pharmaceuticals, Inc., Armstrong Pharmaceuticals, Inc. is a company that manufactures aerosol pharmaceutical products. The company is based in New Canaan, CT. | Corporate Officer/Principal | 01/01/1990 | 01/01/1995 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - | - |
C.R. BARD | Corporate Officer/Principal | - | - |
Neurovance, Inc.
![]() Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Direttore operativo | - | - |
Euthymics Bioscience, Inc.
![]() Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 19/11/2010 | - |
OREXIGEN THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2007 | - |
Formazione di Walter Piskorski
Rensselaer Polytechnic Institute | Undergraduate Degree |
Syracuse University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 6 |
---|---|
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Orexigen Therapeutics, Inc.
![]() Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Armstrong Pharmaceuticals, Inc.
![]() Armstrong Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Amphastar Pharmaceuticals, Inc., Armstrong Pharmaceuticals, Inc. is a company that manufactures aerosol pharmaceutical products. The company is based in New Canaan, CT. | Health Technology |
Euthymics Bioscience, Inc.
![]() Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Neurovance, Inc.
![]() Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
C. R. Bard, Inc. (New Jersey)
![]() C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
- Borsa valori
- Insiders
- Walter Piskorski
- Esperienza